Diagnostic Tests and Look-Alike Conditions

The journey to a Free Sialic Acid Storage Disease (FSASD) diagnosis often involves a combination of biochemical clues, brain imaging, and genetic confirmation. Because this condition is so rare and its symptoms overlap with other disorders, doctors use several specialized tests to piece together the full picture ^[1]. A normal result on a single test does not independently rule in or rule out the disorder.

The Biochemical Clue: Urine Free Sialic Acid

A common first step in investigating FSASD is a urine test to measure free sialic acid (specifically N-acetylneuraminic acid or Neu5Ac). In most cases of FSASD, the amount of free sialic acid in the urine is 10 to 100 times higher than normal ^[1][2].

However, this test has important limitations:

• The “Normal” Result Quirk: In some individuals with the milder Salla disease form, urine sialic acid levels may be only slightly elevated or even completely normal ^[3][4]. A normal urine test does not always mean a person does not have the condition.
• The Sepsis Interaction: A severe infection, particularly pneumococcal sepsis (caused by Streptococcus pneumoniae), can cause a temporary, non-specific secondary increase in urine sialic acid levels ^[5]. This is a real biochemical change caused by the infection breaking off sialic acid from other molecules. Results obtained during a severe infection may be difficult to interpret and should be repeated when clinically appropriate ^[5].

Brain Imaging: Identifying Patterns

If a metabolic disorder is suspected, a brain MRI is often performed. While these findings aren’t unique to FSASD, they provide strong supportive evidence:

• Hypomyelination: An impairment or persistent delay in the development of myelin, the fatty “insulation” that protects nerve fibers and helps signals travel quickly through the brain ^[1][6].
• Thin Corpus Callosum: The corpus callosum is the bridge of nerve fibers that connects the left and right sides of the brain. In FSASD, this bridge is often noticeably thin or underdeveloped ^[1][7].
• Atrophy: Over time, some may show cerebellar atrophy, which is a shrinking of the part of the brain responsible for coordination and balance ^[1][7].

Genetic Testing: Establishing the Diagnosis

A molecular diagnosis is achieved through genetic testing of the SLC17A5 gene. The goal is to identify pathogenic errors in the genetic code that prevent the body from making functional sialin proteins ^[1].

To confirm FSASD, the test must identify biallelic variants—meaning a pathogenic (disease-causing) or likely pathogenic variant must be found on both copies of the SLC17A5 gene ^[1].

• Variants of Uncertain Significance (VUS): Finding a VUS does not confirm the disease, and further parental or functional testing may be needed.
• Deletion/Duplication Analysis: Standard “sequencing” tests can sometimes miss larger chunks of missing or extra genetic material. If the phenotype fits but only one variant is found, doctors may order a more detailed structural analysis ^[8][7].
• Cellular Testing: In rare, complex cases where blood tests are inconclusive, doctors may perform a skin biopsy to grow fibroblasts or look at white blood cells (leukocytes) to measure sialic acid storage directly inside the cells ^[9][4].

Look-Alike Conditions

Several other rare conditions can mimic FSASD. Your medical team will work to rule these out:

• Sialidosis: This is caused by a different gene (NEU1). It results from an enzyme deficiency that leads to the accumulation of sialylated oligosaccharides. It often presents with different clinical features like myoclonus (muscle jerks) and “cherry-red spots” in the eyes ^[10][11].
• Galactosialidosis: This involves a combined deficiency of two enzymes and is caused by the CTSA gene. It can mimic the organ enlargement seen in the severe infantile form of FSASD ^[12][13].
• Sialuria: This is a very rare condition where the body overproduces sialic acid due to GNE variants, leading to elevated sialic acid in the urine, but it is usually a much milder condition developmentally ^[14][15].